Identification of (4-chlorophenyl)(5-hydroxynaphtho[1,2-b]furan-3-yl)methanone as novel COX-2 inhibitor with analgesic profile

Bioorg Med Chem Lett. 2024 Feb 1;100:129631. doi: 10.1016/j.bmcl.2024.129631. Online ahead of print.ABSTRACTChronic pain is a serious problem that affects billions of people worldwide, but current analgesic drugs limit their use in chronic pain management due to their respective side effects. As a first-line clinical drug for chronic pain, COX-2 selective inhibitors can relieve mild to moderate pain, but they also have some problems. The most prominent one is that their analgesic intensity is not enough, and they cannot well meet the treatment needs of chronic pain. Therefore, there is an urgent need to develop COX-2 inhibitors with stronger analgesic intensity. In this article, we used virtual screening method to screen out the structurally novel COX-2 inhibitor for chronic pain management, and conducted a preliminary study on its mechanism of action using molecular dynamics simulation.PMID:38307442 | DOI:10.1016/j.bmcl.2024.129631
Source: Bioorganic and Medicinal Chemistry Letters - Category: Chemistry Authors: Source Type: research